Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Restructuring Plan [Axis] Spinoff [Member] Employee Relocation [Member] Title and Position [Axis] Director [Member] Employee Severance [Member] Related and Nonrelated Parties [Axis] Phil Ray [Member] A Terry [Member] Business Acquisition [Axis] Nika Europe Ltd Nika BioTechnology, Inc. Consolidated Entities [Axis] Nika Europe [Member] Nika Pharmaceuticals Ltd [Member] Equity Interest Type [Axis] C E O [Member] VITAL FE Ownership [Axis] Dimitar Slavchev Savov MICAR 11 LTD Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets:    Cash    Prepaid expenses Total current assets Total assets:    LIABILITIES AND STOCKHOLDERS’ DEFICIT Current Liabilities:          Due to related parties Total Current Liabilities Total Liabilities Commitments and contingencies Stockholders' Deficit:            Preferred Stock; par value $0.0001; 15,000,000             shares authorized; 15,000,000 and 10,000,000 shares             issued and outstanding, respectively            Common Stock; par value $0.0001; 2,700,000,000             shares authorized; 1,026,371,000 and 876,090,000             shares issued and outstanding, respectively            Additional paid-in capital            Accumulated other comprehensive income            Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenue Operating Expenses:          General and administrative          Professional fees Total operating expenses Loss from operations Loss before provision for income taxes Provision for income taxes Net Loss Other comprehensive income:          Foreign currency translation adjustment Comprehensive Loss Earnings Per Share, Basic Earnings Per Share, Diluted Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning Balance, Preferred Shares Beginning Balance, Shares Common control acquisition Common Control Acquisition, Common Shares Issued Net loss for the period ended Ending balance, value Ending Balance, Preferred Shares Ending Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities:    Net Loss    Adjustments to reconcile net loss to net cash used in operating activities:       Common control merger Net cash used in operating activities Cash flows from investing activities: Cash flows from financing activities:       Loans from related parties Net cash provided by financing activities Net change in cash Cash, beginning of period Cash, end of period Supplemental disclosure of cash flow information:      Cash paid for taxes      Cash paid for interest Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] COMMON STOCK PREFERRED STOCK Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] COMMON CONTROL MERGER THER EVENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimate Concentrations of Credit Risk Reclassifications Cash and Cash Equivalents Principles of Consolidation Fair Value of Financial Instruments Stock-Based Compensation Revenue Recognition Recent Accounting Pronouncements Nika BioTechnology, Inc Consolidated Financial Statement Restructuring Cost [Table] Restructuring Cost and Reserve [Line Items] Business Acquisition, Planned Restructuring Activities, Description Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Percentage of Equity , Before Business Combination Percentage of Voting Equity Interests By Merger Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Substantial Doubt about Going Concern, Management's Evaluation Substantial Doubt about Going Concern, Management's Plans, Substantial Doubt Alleviated Related Party Transaction [Table] Related Party Transaction [Line Items] Proceeds from Related Party Debt Short-Term Debt Preferred Stock, Shares Subscribed but Unissued Ownership Percentage Aggrement for Equivalent Number of Votes for Common Shares Business Acquisition, Share Price Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Subsidiary or Equity Method Investee, Sale of Stock [Table] Subsidiary or Equity Method Investee [Line Items] Preferred Stock, Shares Authorized Stock Issued During Period, Shares, Other Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Cash Inventory Accruals Due to related parties Additional paid in capital Accumulated Deficit General and administrative expenses Business Acquisition, Transaction Costs Business Development Contribution of Property Real Estate Investment Property, at Cost Percentage of Ownership of Equity Interest Percentage of Ownership At theTimeTransaction Etimated Framework Price Per Set of ITV-1 Estimated Profits per set of ITV-1 Common Stocks issued due to the Merger with Nika BioTechnology, Inc Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Income (Loss) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Noncash Merger Related Costs Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other